Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason L. Hornick, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Jason Hornick and Justine Barletta.
Connection Strength

1.776
  1. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications. Adv Anat Pathol. 2012 Jul; 19(4):193-203.
    View in: PubMed
    Score: 0.506
  2. Immunohistochemical staining of thyroidectomy specimens for PTEN can aid in the identification of patients with Cowden syndrome. Am J Surg Pathol. 2011 Oct; 35(10):1505-11.
    View in: PubMed
    Score: 0.481
  3. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas. Thyroid. 2019 05; 29(5):666-673.
    View in: PubMed
    Score: 0.203
  4. Radiation-associated neoplasia: clinical, pathological and genomic correlates. Histopathology. 2017 Jan; 70(1):70-80.
    View in: PubMed
    Score: 0.173
  5. Identification of succinate dehydrogenase-deficient bladder paragangliomas. Am J Surg Pathol. 2013 Oct; 37(10):1612-8.
    View in: PubMed
    Score: 0.138
  6. Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma. Histopathology. 2013 Aug; 63(2):187-93.
    View in: PubMed
    Score: 0.135
  7. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma. Am J Surg Pathol. 2010 Aug; 34(8):1193-8.
    View in: PubMed
    Score: 0.111
  8. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011 Jun; 35(6):816-26.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.